Condition

Diabetes Mellitus, Type 2

ClinicalTrials.gov condition label

Clinical trials3,314

Recruiting145

Common interventions25

Lead sponsors shown15

Clinical trials

60 shown

Real-time Engagement for Learning to Effectively Control Type 2 DiabetesNCT06375460 · 2026-09-20

Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to CagrisemaNCT07817251 · 2026-09-16

Diabetes Multimorbidity Typology, Trajectory, and Feasibility of an Audio Diary Mobile Application to Support Self-managementNCT07474376 · 2026-09-01

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular EventNCT07783802 · 2026-08-27

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or OverweightNCT07784270 · 2026-08-20

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 DiabetesNCT07282613 · 2026-08-04

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)NCT07684144 · 2026-07-29

Efficacy, Safety, and Tolerability of Tirzepatide in Real-World Conditions in Paraguay.NCT07588438 · 2026-07-27

A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan FastingNCT07613307 · 2026-07-15

A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 DiabetesNCT07668388 · 2026-06-22

A Trial Evaluating AMG 127 in Healthy Participants and Participants With Type 2 Diabetes MellitusNCT07590193 · 2026-06-11

Milk for Diabetes PreventionNCT06513026 · 2026-05-15

Glucose and Activity Tracking for Sedentary Behavior Interventions in Older People With Type 2 Diabetes (TRACK T2D)NCT07524205 · 2026-05-12

Investigating the Impact of GLP-1 RA Therapy on Osteosarcopenia in Older Female Adults With DiabetesNCT07428746 · 2026-05-07

A Research Study to Evaluate the Safety of NNC1679-0001 When Given to Healthy Participants and Participants With T2DMNCT07570992 · 2026-05-04

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 DiabetesNCT07415954 · 2026-04-17

Improving Health Outcomes With KefirNCT06695221 · 2026-03-24

A Real-world Study to Investigate Cardiovascular Risk Profile Among Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) ParticipantsNCT07532863 · 2026-03-13

Pilot-Testing Real-Time Engagement for Learning to Effectively Control Type 2 DiabetesNCT07270016 · 2026-02-16

Semaglutide for Smoking Cessation in Patients With DiabetesNCT07059377 · 2026-02-13

ROME GS System StudyNCT07518004 · 2026-02-12

DiaMester Pilot RCT: E-health Lifestyle Program for Type 2 DiabetesNCT07361640 · 2026-01-14

Continuous Glucose Monitoring in Non-Insulin Treated Type 2 Diabetes: Continuous vs. Periodic UseNCT07336329 · 2026-01-02

Gemini Study: A Prospective, Multicenter Evaluation of Performance and Safety of the Eversense Gemini System With Flash Glucose Measurement FeatureNCT07386340 · 2025-12-29

Improving Diabetes Care With Strategies For Addressing Health-Related Social Needs and Community PartnershipsNCT07043426 · 2025-12-26

Longitudinal Observational Study of Diabetic Retinopathy Progression in Type 2 Diabetes PatientsNCT07458516 · 2025-11-24

Transformative Research in Diabetic Nephropathy 2.0NCT07444203 · 2025-11-12

Integrated TCM - Western Medicine Strategy for Long - Distance Diabetes ManagementNCT07265037 · 2025-11-01

Nudge-Based Shared Decision Making and Self-Management in Type 2 Diabetes: A Randomized TrialNCT07129915 · 2025-11-01

Drug Interaction Potential of Pro-Inflammatory ConditionsNCT07360938 · 2025-11-01

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 DiabetesNCT07215559 · 2025-10-16

The Effect of Aerobic and Resistance Training in Patients With Type 2 Diabetes on Vitamin D TreatmentNCT06081387 · 2025-10-01

Post Prandial Individual Responses to Different FoodsNCT06989164 · 2025-10-01

Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)NCT06251323 · 2025-09-30

A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 DiabetesNCT07112339 · 2025-08-15

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular DiseaseNCT07064473 · 2025-07-22

The Effects of Henagliflozin on Glucose Fluctuation and Immunosenescence in Type 2 Diabetes Patients on Insulin TherapyNCT06818851 · 2025-07-14

Time-restricted Eating, Window Timing, Type 2 Diabetes Status and Sex on Glycemic ControlNCT06118931 · 2025-06-28

Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled TrialNCT06138821 · 2025-06-24

A Study of LY4057996 in Healthy Participants and Participants With Type 1 and Type 2 DiabetesNCT06945406 · 2025-05-16

Efficacy and Safety of Sanggua Tablets in the Treatment of Patients With Impaired Glucose Tolerance and Mild Type 2 DiabetesNCT06964620 · 2025-05-15

A First-In-Human Study of ARO-ALK7 in Adults With Obesity With and Without Type 2 Diabetes MellitusNCT06937203 · 2025-05-09

Remote Ischemic Conditioning for Non-Proliferative Diabetic RetinopathyNCT06713720 · 2025-04-20

Effects of Vitamin D3 and Yeast Beta-Glucan Supplementation on Glycemic Control and Cardiovascular Disease Risk in Patients With Type 2 DiabetesNCT06861062 · 2025-04-08

The Effect Of Acupressure and Foot Exercise on Ankle Brachial Index in Individuals With Type 2 DiabetesNCT06271382 · 2025-02-24

Regular Use of aPDT in the Management and Prevention of Periodontitis Symptoms in Diabetic PatientsNCT06486012 · 2025-01-23

Autologous SVF Therapy for Type 2 DiabetesNCT07487467 · 2025-01-20

Michigan Men's Diabetes Project III(MenDIII): Mind and MotionNCT06574035 · 2025-01-13

Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or TirzepatideNCT06657209 · 2025-01-13

Postoperative Basal Bolus or Sliding Scale Insulin Regimen in DM2 and Its Effect on Surgical Site Infections.NCT06638567 · 2025-01-03

Single Session vs Multiple-Session Panretinal Photocoagulation for Treatment of Proliferative Diabetic RetinopathyNCT06549023 · 2025-01-01

Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUsNCT06674980 · 2024-12-20

SCS for Patient With Painful Diabetic Neuropathy and Peripheral Arterial DiseaseNCT06480786 · 2024-12-18

Evaluation of Enavogliflozin's Efficacy and Safety in Type II Diabetes With Hypertension or DyslipidemiaNCT06647888 · 2024-12-03

Effect of Meal Replacement Therapy on Glucose Control and Metabolic Parameters in Patients With Uncontrolled DiabetesNCT06862180 · 2024-11-01

Driving with NeuropathyNCT06739135 · 2024-10-25

Effects of Real-time Continuous Glucose Monitoring System on Hospital-to-home Transitional Blood Glucose ControlNCT06591286 · 2024-10-25

A Pragmatic Trial Comparing Empagliflozin and Dapagliflozin Through Cluster Randomization Embedded in the Electronic Health RecordNCT06642272 · 2024-10-10

Food Insecurity Reduction & Strategy TeamNCT06329375 · 2024-10-07

A Study Looking to Improve Sleep and Reduce Sedentary Behaviour in Those Living With Type 2 Diabetes MellitusNCT06471634 · 2024-09-02

Common interventions

Leading sponsors

Novo Nordisk A/S597 Boehringer Ingelheim126 Eli Lilly and Company126 GlaxoSmithKline110 Sanofi78 AstraZeneca45 Pfizer41 Novartis Pharmaceuticals34 Novartis32 Merck Sharp & Dohme LLC29 Janssen Research & Development, LLC26 National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)18 Johnson & Johnson Pharmaceutical Research & Development, L.L.C.17 Takeda17 University of Aarhus17

Trial status mix

COMPLETED2,415

UNKNOWN388

TERMINATED171

RECRUITING145

ACTIVE_NOT_RECRUITING71

WITHDRAWN66

ENROLLING_BY_INVITATION27

NOT_YET_RECRUITING23

SUSPENDED8

Phase mix

NA1,103

PHASE3528

PHASE4404

PHASE1387

PHASE2288

EARLY_PHASE115

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.